How much does a box of clofazimine cost? Domestic and foreign market prices and medical insurance reimbursement in 2025

Clofazimine (Clofazimine) is a antibiotic mainly used to treat leprosy and certain types of bacterial infections. It belongs to the aromatic imine class of drugs, and with its unique antibacterial mechanism, it can effectively inhibit the growth of Mycobacterium leprae. Clinically, clofazimine is often used in combination with other antibiotics to enhance efficacy and reduce the development of resistance.

In China, clofazimine has been officially launched and has been included in the scope of medical insurance reimbursement, which provides great convenience to patients. The common specifications are50mg*10 capsules, and the price per box is about 500 yuan. The specific medical insurance reimbursement amount may vary by region, and patients need to consult the local hospital pharmacy for detailed medical insurance policies and reimbursement ratios. Due to the particularity of leprosy and other related diseases, the introduction of clofazimine has made treatment options more diverse and provided patients with more effective treatment options.

In addition, clofazimine also has relatively cheap generic versions available in the international market. For example, the generic version of clofazimine produced by some overseas pharmaceutical companies is 100mg*100 tablets, and its price is only about 400 yuan. This price has significant advantages over domestic original drugs, and the ingredients of original drugs and generic drugs are basically the same, ensuring the reliability of the efficacy. This price difference allows more patients to afford the treatments they need.

The application of clofazimine is not limited to the treatment of leprosy, it also shows potential in the treatment of some rare diseases or other specific infections. As global attention to diseases such as leprosy increases, the frequency of use of clofazimine has gradually increased. In some countries, this drug is also used to treat other drug-resistant bacterial infections, demonstrating its broad clinical applicability.

Reference materials:https://www.novartis.com/our-products/pipeline/clofazimine